79. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 5. April 2013 (Posterbereich D) 16:00-17:30

Postervorträge

Biomarker bei Herzinsuffizienz

Diskussionsleiter: D. Leistner (Frankfurt am Main), S. Störk (Würzburg), K. Werdan (Halle/Saale)

(P1346) The Toll-like receptor 4 ligands S100A8 and S100A9 are crucial factors in viral cardiomyopathy

P. M. Becher, D. Lindner, K. Savvatis, D. Westermann, T. Vogl, J. Roth, H.-P. Schultheiss, C. Tschöpe (Berlin, Münster)
(P1347) Therapeutic suppression of parvovirus B19 replication with the thymidine analogon telbivudine improves clinical outcome in chronic myocarditis and reduces apoptosis in circulating angiogenic cells

U. Kühl, C.-T. Bock, T. Zobel, C. Schmidt-Lucke, H.-P. Schultheiss (Berlin)
(P1348) Antiviral and immunomodulatory effects restore titin function and extracellular matrix regulation in experimental myocarditis after IL-6 receptor inhibition

P. M. Becher, D. Lindner, W. Linke, N. Hamdani, S. Van Linthout, D. Westermann, H.-P. Schultheiss, C. Tschöpe (Berlin, Bochum)
(P1349) Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, B+ Tenascin-C and ED-A+ Fibronectin in Dilated Cardiomyopathy: Potential Markers for Risk Stratification?

M. Franz, F. Reinbothe, D. Neri, K. Galler, K. Grün, C. Porrmann, G. Mall, P. Schlattmann, H.-R. Figulla, C. Jung, A. Berndt, F. Küthe (Jena, Darmstadt; Zürich, CH)
(P1350) Galectin-3 Predicts Functional Capacity and Clinical Outcome in Heart Failure with Preserved Ejection Fraction (The Aldo-DHF Biomarker Substudy)

K. Durstewitz, V. Holzendorf, R. Wachter, G. Gelbrich, R. Stahrenberg, G. Hasenfuß, B. Pieske, F. Edelmann (Göttingen, Leipzig, Würzburg; Graz, AT)
(P1351) Endostatin serum levels are associated with the presence and severity of left ventricular diastolic dysfunction

W. Dinh, J. Gülker, M. Coll Barroso, W. Nickl, M. Lankisch, R. Füth, T. Köhler, T. Scheffold, S. Schäfer, M. Seyfarth (Wuppertal, Düsseldorf, Freiburg im Breisgau, Gießen)
(P1352) Adrenomedullin als Risikomarker bei Patienten mit akuter Dyspnoe

A. C. Slagman, J. Searle, J. von Recum, C. Müller, J. Vollert, F. Holert, M. Stockburger, M. Möckel (Berlin, Henningsdorf, Nauen)
(P1353) A functional polymorphism in the neuropeptide S receptor gene NPSR1 influences outcome in heart failure

M. Kaspar, S. Kittel-Schneider, S. Störk, D. Berliner, G. Ertl, J. Deckert, A. Reif, C. E. Angermann (Würzburg, Hannover)
(P1354) Kidney injury molecule-1 (KIM-1): additional prognostic value on top of NT-proBNP and hs-TnT in chronic heart failure

S. Stadler, C. Birner, M. Resch, S. Buchner, M. Buesing, G. Riegger, A. Luchner, C. G. Jungbauer (Regensburg)
(P1355) High sensitive procalcitonin predicts early re-hospitalisation for cardiac decompensation in systolic heart failure.

C. Reichert, G. Güder, D. Berliner, S. Störk, G. Ertl, S. Brenner, C. E. Angermann (Würzburg, Hannover)
(P1356) The influence of confounding factors in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure

J. Kube, B. Bigalke, T. Wurster, E. A. Jankowska, P. Rozentryt, M. Cicoira, G. S. Filippatos, P. Ponikowski, W. Döhner, M. Gawaz, S. D. Anker, S. von Haehling (Berlin, Tübingen, Zabrze; Wroclaw, PL; Verona, IT; Athen, GR)